Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

[Difference in the expression of TRAIL mRNA between acute and chronic myeloid leukemia patients and its significance].

Zhang WH, Zhang Y, Ma BG.

Zhonghua Xue Ye Xue Za Zhi. 2013 Feb;34(2):166-8. Chinese. No abstract available.

PMID:
23611229
[PubMed - indexed for MEDLINE]
Free Article
3.

GTPase regulator associated with the focal adhesion kinase (GRAF) transcript was down-regulated in patients with myeloid malignancies.

Qian Z, Qian J, Lin J, Yao DM, Chen Q, Ji RB, Li Y, Xiao GF, Li JY.

J Exp Clin Cancer Res. 2010 Aug 12;29:111. doi: 10.1186/1756-9966-29-111.

PMID:
20704716
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

BCR-ABL regulates death receptor expression for TNF-related apoptosis-inducing ligand (TRAIL) in Philadelphia chromosome-positive leukemia.

Kuroda I, Inukai T, Zhang X, Kikuchi J, Furukawa Y, Nemoto A, Akahane K, Hirose K, Honna-Oshiro H, Goi K, Kagami K, Yagita H, Tauchi T, Maeda Y, Sugita K.

Oncogene. 2013 Mar 28;32(13):1670-81. doi: 10.1038/onc.2012.186. Epub 2012 Jun 4.

PMID:
22665066
[PubMed - indexed for MEDLINE]
6.

Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias.

Burger H, Nooter K, Zaman GJ, Sonneveld P, van Wingerden KE, Oostrum RG, Stoter G.

Leukemia. 1994 Jun;8(6):990-7.

PMID:
7911548
[PubMed - indexed for MEDLINE]
7.

[Molecular biology and FAB classification].

Ohyashiki J, Tauchi T, Ohyashiki K, Toyama K.

Rinsho Ketsueki. 1992 May;33(5):608-12. Japanese. No abstract available.

PMID:
1630012
[PubMed - indexed for MEDLINE]
8.

[Expression and its significance of TRAIL and its receptors in cells of patients with acute myeloid leukemia].

Zhao S, Wang HX, Mao H, Xiao J, Zou P.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Feb;13(1):65-9. Chinese.

PMID:
15748438
[PubMed - indexed for MEDLINE]
9.

BCR-ABL-mediated upregulation of PRAME is responsible for knocking down TRAIL in CML patients.

De Carvalho DD, Binato R, Pereira WO, Leroy JM, Colassanti MD, Proto-Siqueira R, Bueno-Da-Silva AE, Zago MA, Zanichelli MA, Abdelhay E, Castro FA, Jacysyn JF, Amarante-Mendes GP.

Oncogene. 2011 Jan 13;30(2):223-33. doi: 10.1038/onc.2010.409. Epub 2010 Sep 13.

PMID:
20838376
[PubMed - indexed for MEDLINE]
10.

Frequency of BCR-ABL fusion transcripts in Iranian patients with chronic myeloid leukemia.

Yaghmaie M, Ghaffari SH, Ghavamzadeh A, Alimoghaddam K, Jahani M, Mousavi SA, Irvani M, Bahar B, Bibordi I.

Arch Iran Med. 2008 May;11(3):247-51. doi: 08113/AIM.003.

PMID:
18426313
[PubMed - indexed for MEDLINE]
Free Article
11.

B-lymphoid/myeloid stem cell origin in Ph-positive acute leukemia with myeloid markers.

Akashi K, Taniguchi S, Nagafuji K, Harada M, Shibuya T, Hayashi S, Gondo H, Niho Y.

Leuk Res. 1993 Jul;17(7):549-55.

PMID:
8326735
[PubMed - indexed for MEDLINE]
12.

Detection of bcr/abl fusion transcripts by semiquantitative multiplex RT-PCR combined with a colormetric assay in Ph positive leukemia.

Ni H, Nitta M, Komatsu H, Kojima S, Suzuki S, Harada S, Tsuboi K, Banno S, Wakita A, Yazaki M, Ren L, Kato T, Ueda R.

Cancer Lett. 1998 Feb 27;124(2):173-80.

PMID:
9500207
[PubMed - indexed for MEDLINE]
13.

[Molecular analysis of bcr-abl mRNA during long-term follow-up of cases of chronic myelogenous leukemia].

Nakamura K, Okamoto N, Mizutani S.

Rinsho Ketsueki. 1994 Sep;35(9):853-61. Japanese.

PMID:
7967054
[PubMed - indexed for MEDLINE]
14.

[Role of molecular screening for common fusion genes in the diagnosis and classification of leukemia].

Zhu YL, Zhang Y, Zhu P, Yang Y, Du JW, Liu J.

Beijing Da Xue Xue Bao. 2005 Jun 18;37(3):236-9. Chinese.

PMID:
15968309
[PubMed - indexed for MEDLINE]
Free Article
15.

[Effect of gemcitabine on granulocyte colony-stimulating factor receptor and bcr/abl mRNA in patients with chronic myeloid leukemia].

Liu D, Wang F, Sun L, Liu LX, Liu YF, Ling Z, Han XF.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Oct;18(5):1168-71. Chinese.

PMID:
21129254
[PubMed - indexed for MEDLINE]
16.

Near-hexaploid Ph-positive acute myeloid leukemia with major-BCR/ABL transcript.

Iwama H, Ohyashiki K, Ohyashiki JH, Shimamoto T, Fujimura T, Kawakubo K, Kuriyama Y, Kodama A, Toyama K.

Cancer Genet Cytogenet. 1996 Jan;86(1):61-4.

PMID:
8616789
[PubMed - indexed for MEDLINE]
17.

Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression.

Gaiger A, Henn T, Hörth E, Geissler K, Mitterbauer G, Maier-Dobersberger T, Greinix H, Mannhalter C, Haas OA, Lechner K, Lion T.

Blood. 1995 Sep 15;86(6):2371-8.

PMID:
7662984
[PubMed - indexed for MEDLINE]
Free Article
18.

p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias.

van Rhee F, Hochhaus A, Lin F, Melo JV, Goldman JM, Cross NC.

Blood. 1996 Jun 15;87(12):5213-7.

PMID:
8652835
[PubMed - indexed for MEDLINE]
Free Article
19.

A Ph+ acute myeloid leukaemia expressing both CML-type and ALL-type BCR/ABL mRNA transcripts.

Williams BG, Yin JL, Ma DD.

Leuk Lymphoma. 1994 Jul;14(3-4):341-6.

PMID:
7950925
[PubMed - indexed for MEDLINE]
20.

[Molecular analysis of bcr/abl mRNA in chronic myelogenous leukemia after bone marrow transplantation by using RT-PCR method].

Nakamura K, Mizutani S, Matsue T.

Rinsho Ketsueki. 1992 Apr;33(4):436-44. Japanese.

PMID:
1602606
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk